BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 11759958)

  • 1. The correlation of beta-subunit human chorionic gonadotropin level in the serum and first morning urine of patients with gestational trophoblastic disease.
    Benjapibal M; Wataganara T; Senawong S; Boriboonhirunsarn D; Suphanit I
    J Med Assoc Thai; 2001 Jul; 84(7):1000-5. PubMed ID: 11759958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gestational trophoblastic diseases: 3. Human chorionic gonadotropin-free beta-subunit, a reliable marker of placental site trophoblastic tumors.
    Cole LA; Khanlian SA; Muller CY; Giddings A; Kohorn E; Berkowitz R
    Gynecol Oncol; 2006 Aug; 102(2):160-4. PubMed ID: 16631918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human chorionic gonadotropin free beta-subunit measurement as a marker of placental site trophoblastic tumors.
    Harvey RA; Pursglove HD; Schmid P; Savage PM; Mitchell HD; Seckl MJ
    J Reprod Med; 2008 Aug; 53(8):643-8. PubMed ID: 18773632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood test for placental site trophoblastic tumor and nontrophoblastic malignancy for evaluating patients with low positive human chorionic gonadotropin results.
    Cole LA; Khanlian SA; Muller CY
    J Reprod Med; 2008 Jul; 53(7):457-64. PubMed ID: 18720919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
    Shaarawy M; Darwish NA; Abdel-Aziz O
    J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring human chorionic gonadotrophin level: evaluation of urine as an alternative specimen type.
    Chen YN; Deng MD; Zeng LJ; Wu MY
    Br J Biomed Sci; 1999; 56(3):199-203. PubMed ID: 10824329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maternal serum free beta-hCG levels in uncomplicated pregnancies at the 10th-15th week of gestation and the development of obstetric complications.
    De León J; Sifuentes G; Hopkins C; Noble V; Gimpel T; Myles T; Santolaya-Forgas J
    J Reprod Med; 2004 Feb; 49(2):89-92. PubMed ID: 15018435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Following metastatic placental site trophoblastic tumor with urine beta-core fragment.
    Rinne K; Shahabi S; Cole L
    Gynecol Oncol; 1999 Aug; 74(2):302-3. PubMed ID: 10419751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
    Cole LA; Sutton JM
    J Reprod Med; 2004 Jul; 49(7):545-53. PubMed ID: 15305826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum beta human chorionic gonadotropin levels and preeclampsia.
    Basirat Z; Barat S; Hajiahmadi M
    Saudi Med J; 2006 Jul; 27(7):1001-4. PubMed ID: 16830019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A conservative approach in persistent low-level elevation of serum beta-human chorionic gonadotropin following chemotherapy for gestational trophoblastic neoplasia.
    Boafo-Yirenki M; Everard J; Tidy J; Hancock BW
    J Reprod Med; 2009 May; 54(5):288-90. PubMed ID: 19517692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of hCG in trophoblastic disease. The USA hCG reference service experience.
    Cole LA; Butler S
    J Reprod Med; 2002 Jun; 47(6):433-44. PubMed ID: 12092011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endometrial adenocarcinoma associated with elevated serum concentrations of the free beta subunit of human chorionic gonadotropin.
    Grenache DG; Moller KA; Groben PM
    Am J Clin Pathol; 2004 May; 121(5):748-53. PubMed ID: 15151215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CSF/serum beta-hCG ratio in patients with brain metastases of gestational trophoblastic tumor.
    Bakri Y; al-Hawashim N; Berkowitz R
    J Reprod Med; 2000 Feb; 45(2):94-6. PubMed ID: 10710737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum human chorionic gonadotropin regression pattern in persistent trophoblastic disease during chemotherapy.
    Lertkhachonsuk R; Limpongsanurak S
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S352-9. PubMed ID: 11529357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accuracy of a semi-quantitative urine pregnancy test compared to serum beta-hCG measurement: a possible screening tool for ongoing pregnancy after medication abortion.
    Grossman D; Berdichevsky K; Larrea F; Beltran J
    Contraception; 2007 Aug; 76(2):101-4. PubMed ID: 17656178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of gestational trophoblastic disease and other cases with low serum levels of human chorionic gonadotropin.
    Khanlian SA; Cole LA
    J Reprod Med; 2006 Oct; 51(10):812-8. PubMed ID: 17086809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and outcome of healthy women with a persistently elevated beta-hCG.
    Palmieri C; Dhillon T; Fisher RA; Young AM; Short D; Mitchell H; Aghajanian C; Savage PM; Newlands ES; Hancock BW; Seckl MJ
    Gynecol Oncol; 2007 Jul; 106(1):35-43. PubMed ID: 17482245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.